Indication
Pulmonary tuberculosis
Pulmonary tuberculosis is a contagious bacterial infection of the respiratory system caused by Mycobacterium tuberculosis, primarily affecting the lung parenchyma. Read more about Pulmonary tuberculosis
104 drugs 72 manufacturers
Drugs that treat it
Common Pulmonary tuberculosis therapies.
ISONIAZID
PREDNISONE
ISONIAZID
ISONIAZID
PREDNISONE
ETHAMBUTOL HCL
PREDNISONE
PREDNISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPulmonary tuberculosis is a contagious bacterial infection of the respiratory system caused by Mycobacterium tuberculosis, primarily affecting the lung parenchyma.
Transmission occurs through inhalation of aerosolized droplets, inciting a localized host immune response characterized pathologically by granulomatous inflammation, caseating necrosis, and potential cavitary formation.
The clinical disease may manifest shortly after initial exposure as primary infection or arise years later via reactivation of a dormant, latent infection.
Defining clinical features typically include a persistent productive cough, hemoptysis, pleuritic chest pain, fever, drenching night sweats, fatigue, and unintended weight loss.
- nih.gov
Pulmonary tuberculosis is a contagious bacterial infection of the respiratory system caused by Mycobacterium tuberculosis, primarily affecting the lung parenchyma Transmission occurs through inhalation of aerosolized droplets, inciting a localized host immune response characterized pathologically by granulomatous inflammation, caseating necrosis, and potential cavitary formation The clinical disease may manifest shortly after initial exposure as primary infection or arise years later via reactiv...
- medlineplus.gov
Pulmonary tuberculosis is a contagious bacterial infection of the respiratory system caused by Mycobacterium tuberculosis, primarily affecting the lung parenchyma
- nih.gov
Transmission occurs through inhalation of aerosolized droplets, inciting a localized host immune response characterized pathologically by granulomatous inflammation, caseating necrosis, and potential cavitary formation The clinical disease may manifest shortly after initial exposure as primary infection or arise years later via reactivation of a dormant, latent infection
- cdc.gov
Transmission occurs through inhalation of aerosolized droplets, inciting a localized host immune response characterized pathologically by granulomatous inflammation, caseating necrosis, and potential cavitary formation
- cdc.gov
Defining clinical features typically include a persistent productive cough, hemoptysis, pleuritic chest pain, fever, drenching night sweats, fatigue, and unintended weight loss
Personalize your experience
Follow Pulmonary tuberculosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.